Lysosomes Contribute to Anomalous Pharmacokinetic Behavior of Melanocortin-4 Receptor Agonists

Author： Gong Yuping   Zhao Zhiyang   McConn Donavon   Beaudet Beth   Tallman Melanie   Speake Jason   Ignar Diane   Krise Jeffrey  

Publisher： Springer Publishing Company

ISSN： 0724-8741

Source： Pharmaceutical Research, Vol.24, Iss.6, 2007-06, pp. : 1138-1144

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Recent advances in the development of melanocortin-4 receptor agonists

By Speake Jason D   Bishop Michael J  

Expert Opinion on Therapeutic Patents, Vol. 12, Iss. 11, 2002-11 ,pp. : 1631-1638

Informa Healthcare

Access to resources Recommend Favorite

Melanocortin - 4 Receptor Agonists for the Treatment of Obesity

By  

Current Topics in Medicinal Chemistry, Vol. 7, Iss. 11, 2007-06 ,pp. : 1121-1130

Bentham Science Publishers

Access to resources Recommend Favorite

Structure-Activity Relationships of &bgr; -MSH Derived Melanocortin-4 Receptor Peptide Agonists

By  

Current Topics in Medicinal Chemistry, Vol. 7, Iss. 11, 2007-06 ,pp. : 1052-1067

Bentham Science Publishers

Access to resources Recommend Favorite

Promising Strategies for Obesity Pharmacotherapy: Melanocortin-4 (MC- 4) Receptor Agonists and Melanin Concentrating Hormone (MCH) Receptor-1 Antagonists

By  

Current Topics in Medicinal Chemistry, Vol. 9, Iss. 6, 2009-04 ,pp. : 504-538

Bentham Science Publishers

Access to resources Recommend Favorite

Melanocortin receptor agonists and antagonists modulate nociceptive sensitivity in the mouse formalin test

By Bellasio S.   Nicolussi E.   Bertorelli R.   Reggiani A.  

European Journal of Pharmacology, Vol. 482, Iss. 1, 2003-12 ,pp. : 127-132

Elsevier

Access to resources Recommend Favorite